Clinical Trial Update: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

View source ↗

Summary

A clinical trial update on mogamulizumab (Poteligeo) assessing safety and efficacy through use-result surveillance in patients with mycosis fungoides and Sézary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Poteligeo (mogamulizumab)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Mycosis Fungoides, Sezary Syndrome | Status: RECRUITING